HHMI Invests $300 Million in 33 New Investigators hhmi.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hhmi.org Daily Mail and Mail on Sunday newspapers.
World s Most Successful Athletic Fundraiser, the Pan-Mass Challenge, Returns to the Road for 2021 Ride prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Posted August 2nd, 2021 for Dana Farber
Six-episode season explores the stories behind some of the most important cancer research Dana-Farber Cancer Institute is launching a new podcast series, titled
Unraveled , to explain the science behind some of the most important breakthroughs in cancer research. The six-episode season premieres August 9
th with “A Sheep in Wolf’s Clothing.” The first episode tells the story behind the discovery of PD-L1, which helped launch a new era of cancer immunotherapy. In this episode, the series host, veteran journalist Ken Shulman, talks with Gordon Freeman, PhD , a researcher at Dana-Farber, whose research formed a foundation for the immune checkpoint blockade immunotherapies used today, and a lung cancer patient, Barry Nelson, whose life was saved by one of the first such drugs.
Date Time
Dana-Farber Cancer Institute Establishes David Liposarcoma Research Initiative
Dana-Farber Cancer Institute announced that The Rossy Foundation has committed $10 million to establish the David Liposarcoma Research Initiative. The five-year initiative will spearhead groundbreaking research into liposarcoma at Dana-Farber and external collaborating partner institutions, with the aim of transforming the treatment of this rare, underfunded, and understudied disease in order to improve care of patients through research.
This commitment from The Rossy Foundation will focus on collaborative research among various departments at Dana-Farber-including liposarcoma biology, biochemistry, immunology, metabolism, genomics, and epigenetics. By conducting research to improve fundamental understanding of the molecular mechanisms of this disease, the initiative may lead to new approaches to overcome treatment resistance, as well as new strategies for clinical research to improve the outc